These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Some thoughts on surgical adjuvant studies in lung cancer. Carter SK Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314 [No Abstract] [Full Text] [Related]
24. New agents and combinations in the treatment of bronchogenic carcinoma. Bodey GP; Gottlieb JA; Livingston R; Frei E Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740 [No Abstract] [Full Text] [Related]
25. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer. Green MR J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551 [No Abstract] [Full Text] [Related]
26. Chemotherapy for lung cancer by intra-aortic infusion. Freckman HA; Mendez FL; Maurer ER; Fry HL JAMA; 1966 Apr; 196(1):5-10. PubMed ID: 5952189 [No Abstract] [Full Text] [Related]
27. Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation? Hansen HH Cancer Chemother Rep 3; 1973 Mar; 4(2):239-41. PubMed ID: 4354042 [No Abstract] [Full Text] [Related]
28. [Principles in the treatment of malignant pulmonary tumors with cyostatics]. Debevec M Plucne Bolesti Tuberk; 1974; 26(1):45-8. PubMed ID: 4137455 [No Abstract] [Full Text] [Related]
29. [General criteria in therapeutic management of pulmonary cancer]. Galassi A; Campanini A; Bettini L; Tessari R Arch Monaldi; 1971; 26(6):591-4. PubMed ID: 5154926 [No Abstract] [Full Text] [Related]
30. [Internal cancer therapy: cooperative clinical studies. Principles, organization and first results of the Swiss chemotherapy group]. Praxis; 1967 Dec; 56(50):1691-5. PubMed ID: 5632569 [No Abstract] [Full Text] [Related]
32. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage]. Scanni A; Tomirotti M; Biraghi M; Annibali E; Del Bianco S Minerva Med; 1980 Mar; 71(10):799-801. PubMed ID: 7360368 [No Abstract] [Full Text] [Related]
33. [Preliminary evaluation of intermittent polychemotherapy in high doses for prevention of recurrence after radical operation of lung cancer (author's transl)]. Karrer K; Pridun N; Zwintz E Arch Geschwulstforsch; 1973; 42(4):316-23. PubMed ID: 4802890 [No Abstract] [Full Text] [Related]
34. [Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)]. Decroix G; Sors C; Feldman A; Fournier M Bull Mem Soc Med Hop Paris; 1968; 119(2):169-78. PubMed ID: 5670365 [No Abstract] [Full Text] [Related]
36. [Immediate results of polychemotherapy of patients with 3-4 stage lung cancer]. Kasianenko IV; Ierusalimskii EL; Omelchenko AT Vrach Delo; 1973 Feb; 2():61-3. PubMed ID: 4722333 [No Abstract] [Full Text] [Related]
37. Chemotherapy and lung cancer. N Z Med J; 1971 Jun; 73(469):366-7. PubMed ID: 4934328 [No Abstract] [Full Text] [Related]
38. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin. Drago JR; Goldman L; Gershwin ME Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017 [TBL] [Abstract][Full Text] [Related]
39. [How could the results of surgical treatment of bronchogenic carcinoma be improved? (authors transl)]. Denck H Wien Klin Wochenschr; 1978 Apr; 90(8):275-83. PubMed ID: 636442 [No Abstract] [Full Text] [Related]
40. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung. Vincent RG; Lane WW; Raza S; Madajewicz S Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]